Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer

• Jinhua Wang ,

  Contributed equally to this work with: Jinhua Wang, Ashok Sharma

  Affiliations Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America, Sino-American Cancer Research Institute at Nanjing University of Technology and Jiangsu Cancer Hospital, Nanjing, Jiangsu province, China, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, Jiangsu, China, Institute of Translational Medicine, School of Pharmaceutical Sciences, Nanjing University of Technology, Nanjing, Jiangsu province, China

  ⨯
• Ashok Sharma ,

  Contributed equally to this work with: Jinhua Wang, Ashok Sharma

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Sharad A. Ghamande,

  Affiliation Department of Obstetrics and Gynecology, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Stephen Bush,

  Affiliation Department of Obstetrics and Gynecology, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Daron Ferris,

  Affiliation Department of Obstetrics and Gynecology, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Wenbo Zhi,

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Mingfang He,

  Affiliations Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America, Sino-American Cancer Research Institute at Nanjing University of Technology and Jiangsu Cancer Hospital, Nanjing, Jiangsu province, China, Institute of Translational Medicine, School of Pharmaceutical Sciences, Nanjing University of Technology, Nanjing, Jiangsu province, China

  ⨯
• Meiyao Wang,

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Xiaoxiao Wang,

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Eric Miller,

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Diane Hopkins,

  Affiliation Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Michael Macfee,

  Affiliation Department of Obstetrics and Gynecology, Georgia Health Sciences University, Augusta, Georgia, United States of America

  ⨯
• Ruili Guan,

  Affiliations Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America, Institute of Urological Surgery, First Hospital of Beijing University, Beijing, China

  ⨯
• Jinhai Tang,

  Affiliations Sino-American Cancer Research Institute at Nanjing University of Technology and Jiangsu Cancer Hospital, Nanjing, Jiangsu province, China, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Jin-Xiong She

  * E-mail: jshe@gru.edu

  Affiliations Center for Biotechnology and Genomic Medicine, Georgia Health Sciences University, Augusta, Georgia, United States of America, Sino-American Cancer Research Institute at Nanjing University of Technology and Jiangsu Cancer Hospital, Nanjing, Jiangsu province, China, Institute of Translational Medicine, School of Pharmaceutical Sciences, Nanjing University of Technology, Nanjing, Jiangsu province, China

  ⨯